BR0112984A - Thiazolidinedione derivative tartrate salts - Google Patents

Thiazolidinedione derivative tartrate salts

Info

Publication number
BR0112984A
BR0112984A BR0112984-8A BR0112984A BR0112984A BR 0112984 A BR0112984 A BR 0112984A BR 0112984 A BR0112984 A BR 0112984A BR 0112984 A BR0112984 A BR 0112984A
Authority
BR
Brazil
Prior art keywords
compound
tartrate salts
thiazolidinedione derivative
derivative tartrate
salts
Prior art date
Application number
BR0112984-8A
Other languages
Portuguese (pt)
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Michael Millan
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of BR0112984A publication Critical patent/BR0112984A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

"SAIS TARTARATO DE DERIVADO DE TIAZOLIDINODIONA". Trata-se de um novo composto farmacêutico mesotartarato de 5-[4-2-(N-metil-N-(2-piridil) amino) etoxi] benzil] tiazolidono-2,4-diona ou um seu solvato, um processo para preparação de um tal composto, uma composição farmacêutica compreendendo um tal composto e o uso de um tal composto em medicina."TIAZOLIDINDIONA DERIVATIVE TARTARATE SALTS". It is a new 5- [4-2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidone-2,4-dione mesotartarate pharmaceutical compound or a solvate thereof, a process for preparation of such a compound, a pharmaceutical composition comprising such a compound and the use of such a compound in medicine.

BR0112984-8A 2000-08-04 2001-08-03 Thiazolidinedione derivative tartrate salts BR0112984A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
BR0112984A true BR0112984A (en) 2003-06-10

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0112984-8A BR0112984A (en) 2000-08-04 2001-08-03 Thiazolidinedione derivative tartrate salts

Country Status (23)

Country Link
EP (1) EP1307448A1 (en)
JP (1) JP2004505971A (en)
KR (1) KR20030022356A (en)
CN (1) CN1458930A (en)
AP (1) AP2003002737A0 (en)
AU (1) AU2001276508A1 (en)
BG (1) BG107605A (en)
BR (1) BR0112984A (en)
CA (1) CA2417828A1 (en)
CZ (1) CZ2003314A3 (en)
EA (1) EA200300231A1 (en)
EC (1) ECSP034468A (en)
GB (1) GB0019226D0 (en)
HU (1) HUP0300770A2 (en)
IL (1) IL154277A0 (en)
MA (1) MA25830A1 (en)
MX (1) MXPA03001086A (en)
NO (1) NO20030508L (en)
OA (1) OA12355A (en)
PL (1) PL360702A1 (en)
SK (1) SK1452003A3 (en)
WO (1) WO2002012233A1 (en)
ZA (1) ZA200300962B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (en) * 2002-10-11 2005-07-08 Servier Lab ASSOCIATION BETWEEN A LIGAND OF RECEPTORS ACTIVE BY PEROXISOME PROLIFIERS AND AN ANTIOXIDANT AGENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7264813B2 (en) * 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (en) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 The preparation method of Tartraric rosiglitazone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
NO20030508L (en) 2003-03-20
IL154277A0 (en) 2003-09-17
WO2002012233A1 (en) 2002-02-14
EA200300231A1 (en) 2003-06-26
ZA200300962B (en) 2003-10-29
CZ2003314A3 (en) 2004-02-18
HUP0300770A2 (en) 2003-11-28
AU2001276508A1 (en) 2002-02-18
EP1307448A1 (en) 2003-05-07
CN1458930A (en) 2003-11-26
ECSP034468A (en) 2003-03-31
AP2003002737A0 (en) 2003-03-31
CA2417828A1 (en) 2002-02-14
JP2004505971A (en) 2004-02-26
PL360702A1 (en) 2004-09-20
GB0019226D0 (en) 2000-09-27
SK1452003A3 (en) 2004-05-04
NO20030508D0 (en) 2003-01-31
MA25830A1 (en) 2003-07-01
KR20030022356A (en) 2003-03-15
BG107605A (en) 2003-09-30
OA12355A (en) 2004-03-19
MXPA03001086A (en) 2003-05-27

Similar Documents

Publication Publication Date Title
BR0108870A (en) Hydrochloride salts of 5- [4- [2- (n-methyl-n- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione
BRPI0606768A2 (en) oral dosage form comprising rosiglitazone
CY1106226T1 (en) 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINO-2,4-DIONE MESYLATE SALT
BR0112981A (en) Thiazolidinedione derivative tartrate salts
BR0112984A (en) Thiazolidinedione derivative tartrate salts
CY1105354T1 (en) A THIAZOLIDINODIONE DERIVATIVE AND ITS USE AS AN ANTI-DIABETIC
BR0113713A (en) 5- [4- [2- (methyl-n- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine -2,4-dione hydrochloride salt
BR0112983A (en) Thiazolidinedione derivative tartrate salts
BR0112982A (en) Thiazolidinedione derivative tartrate salt
DK1446404T3 (en) Rosiglitazone disylates and their use as antidiabetics
BR0111536A (en) Thiazolidinedione salt for diabetes mellitus treatment
DK1315721T3 (en) A thiazolidinedione derivative and its use as an antidiabetic agent
AP1738A (en) Sodium salts of 5-[4-[2-(N-Methyl -N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione.
BR0111508A (en) 5- (4- (2- (n-Methyl- (2-pyridyl) amino) ethoxy) benzyl) thiazolidine-2,4dione hydrochloride as a pharmaceutical substance
BR0114364A (en) Thiazolidinedione derivative and its use as an anti-diabetic
RS50130B (en) Pharmaceutical composition 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy) benzyl)thiazolidine-2,4-dione
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 4A,5A,6AE7A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1963 DE 19.08.2008.